Integrating HIV and substance misuse services: a person-centred approach grounded in human rights.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
08 2022
Historique:
received: 26 01 2022
revised: 19 04 2022
accepted: 19 04 2022
pubmed: 25 6 2022
medline: 20 7 2022
entrez: 24 6 2022
Statut: ppublish

Résumé

Integrating HIV-related care with treatment for substance use disorder provides an opportunity to better meet the needs of people living with these conditions. People with substance use disorder are rendered especially vulnerable by prevailing policies, structural inequalities, and stigmatisation. In this Series paper we analyse existing literature and empirical evidence from scoping reviews on integration designs for the treatment of HIV and substance use disorder, to understand barriers to and facilitators of care integration and to map ways forward. We discuss how approaches to integration address two core gaps in current models: a failure to consider human rights when incorporating the perspectives of people living with HIV and people who use drugs, and a failure to reflect critically on structural factors that determine risk, vulnerability, health-care seeking, and health equity. We argue that successful integration requires a person-centred approach, which is grounded in human rights, treats both concerns holistically, and reconnects with underlying social, economic, and political inequalities.

Identifiants

pubmed: 35750060
pii: S2215-0366(22)00159-6
doi: 10.1016/S2215-0366(22)00159-6
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

676-688

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Auteurs

Victoria Haldane (V)

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.

Anne-Sophie Jung (AS)

School of Politics and International Studies, University of Leeds, Leeds, UK. Electronic address: a.s.jung@leeds.ac.uk.

Chuan De Foo (C)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore; National University Health System, Singapore.

Pami Shrestha (P)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore; National University Health System, Singapore.

Elena Urdaneta (E)

Doctors of the World, Madrid, Spain.

Eva Turk (E)

Institute for Health and Society, University of Oslo, Oslo, Norway; Medical Faculty, University of Maribor, Maribor, Slovenia.

Juan I Gaviria (JI)

Coordinación de Vigilancia Epidemiologica e Infectologia, Hospital del Instituto Ecuatoriano del Seguro Social (IESS) Sur de Quito, Quito, Ecuador.

Jesus Boadas (J)

Centro de Rehabilitación Mental ANSALUD, Santo Domingo, Dominican Republic.

Kent Buse (K)

The George Institute for Global Health, Imperial College London, London, UK.

J Jaime Miranda (JJ)

Universidad Peruana Cayetano Heredia, Lima, Peru; The George Institute for Global Health, UNSW, Sydney, NSW, Australia.

Steffanie A Strathdee (SA)

Department of Medicine, University of California San Diego, La Jolla, CA, USA.

Ashley Barratt (A)

Positive21, London, UK; ReShape/International HIV Partnerships-European Chemsex Forum, London, UK.

Michel Kazatchkine (M)

Global Commission on Drug Policy, Geneva, Switzerland.

Martin McKee (M)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Helena Legido-Quigley (H)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore; National University Health System, Singapore; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH